Download Sample
Schedule a Meeting
NA : +1 804 441 9344
sales@towardshealthcare.com
August 2025
The global minimally invasive surgery market size is calculated at US$ 81.69 billion in 2024, grew to US$ 94.8 billion in 2025, and is projected to reach around US$ 362.43 billion by 2034. The market is expanding at a CAGR of 16.05% between 2025 and 2034.
The use of minimally invasive surgeries is increasing globally due to growing patient demands. This, in turn, is driving their innovations as well as growing the collaboration and investments to accelerate their development. The use of AI is also increasing to enhance its applications and improve patient outcomes. Their use is also increasing in various regions due to the growing adoption of robotic-assisted surgery and growing medical tourism. Moreover, the companies are also contributing to these advancements by launching new systems. Thus, this is promoting the market growth.
| Table | Scope |
| Market Size in 2025 | USD 94.8 Billion |
| Projected Market Size in 2034 | USD 362.43 Billion |
| CAGR (2025 - 2034) | 16.05% |
| Leading Region | North America 42% |
| Market Segmentation | By Procedure Type, By Device Type, By Application, By End User, By Region |
| Top Key Players | Medtronic plc, Johnson & Johnson (Ethicon, DePuy Synthes), Stryker Corporation, Intuitive Surgical, Inc., Olympus Corporation, Boston Scientific Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Karl Storz SE & Co. KG, CONMED Corporation, FUJIFILM Holdings Corporation, Cook Medical Inc., Applied Medical Resources Corporation, Richard Wolf GmbH, Arthrex, Inc., Siemens Healthineers AG, GE HealthCare Technologies, Inc. , Accuray Incorporated, Globus Medical, Inc., B. Braun Melsungen AG |
The minimally invasive surgery market encompasses surgical techniques that use small incisions, specialized instruments, cameras, and robotics to reduce tissue trauma compared to traditional open surgery. MIS offers patients shorter recovery times, reduced pain, fewer complications, and lower healthcare costs. It is widely adopted across laparoscopy, endoscopy, arthroscopy, interventional cardiology, and robotic-assisted procedures. Growing prevalence of chronic diseases (cardiac, orthopedic, gastrointestinal, gynecological, and urological disorders), rising adoption of robotics and image-guided systems, and increasing patient demand for faster recovery are fueling market growth.
Increasing demand for MIS: There is a rise in the demand for MIS due to its less pain, scarring, and faster recovery. This, in turn, is increasing their adoption as well as advancements to enhance their applications. Therefore, the collaborations among the companies and investments are increasing to accelerate these innovations.
For instance,
The advancements in surgical medicine are being represented by the integration of minimally invasive surgical practices with AI. The AI-powered predictive analytics, real-time navigation, robotic systems, and enhanced imaging can improve the unprecedented efficiency and accuracy of the surgeons. Additionally, safer procedures and quicker patient recoveries can be achieved with the use of personalized AI-driven autonomous instruments and surgical planning. The accessibility of surgical expertise and precision can be enhanced with the use of AI-driven surgical training, augmented reality integration, and telerobotic surgery. Thus, with the use of AI the patient safety and experiences can be enhanced with minimal complexities.
Growing Innovations
Due to growing patient demand, there is a rise in the use of minimally invasive surgeries. This, in turn, is enhancing their innovations to improve applications. To enhance the visualization, 3D imaging techniques are being developed. To enhance their portability, smaller and flexible tools are also being developed. At the same time, to reduce the workload and enhance the accuracy, autonomous systems are also being developed. Moreover, techniques with few incisions, such as natural orifice transluminal endoscopic surgery (NOTES), are also being developed. Thus, this drives the minimally invasive surgery market growth.
High Cost
The minimally invasive systems or technologies used during surgeries are costly. They also require regular maintenance to maintain their system operations. Moreover, training is also required for their proper handling. Thus, this makes the installation of the surgeries more costly, limiting their utilization by the hospitals.
Increasing Applications in Endoscopic Surgeries
The demand for endoscopic surgeries is increasing due to growing applications for diagnostics as well as surgical procedures. They are being used for tumor removal as well as for stent placement. At the same time, their lower pain and scarring are increasing their demand as this promotes faster recovery of the patients. Additionally, their increasing innovations are enhancing their accuracy and safety, which is increasing their use for various procedures. This, in turn, is driving their use for ureteroscopy, bronchoscopy, polypectomy, hysteroscopy, etc. Thus, all these advancements are promoting the minimally invasive surgery market growth.
For instance,
By procedure type, the laparoscopic surgery segment held the largest share of the market with approximately 38% in 2024, due to its wide range of applications. It also reduced the recovery period due to its small incision. It also reduced the chances of infections. Moreover, their increased availability also increased their adoption rates.
By procedure type, the robotic-assisted surgery segment is expected to show the fastest growth rate during the predicted time. It provided 3D imaging, which increases the visualization during the surgical process. Its small incision and enhanced accuracy are also increasing its use. This, in turn, is increasing its applications, promoting its use.
By device type, the endoscopes & laparoscopes segment led the market with approximately a 36% share in 2024, as it was widely used for imaging the internal organs. This, in turn, increased their use in various healthcare fields. Additionally, their use for early diagnosis of diseases also increased.
By device type, the robotic surgical systems segment is expected to show the highest growth during the predicted time. These systems offer higher precision, which is increasing their use in complex procedures. Moreover, their enhanced visualization and smaller incisions are also promoting their use. This is enhancing their use for various applications.
By application type, the general surgery segment held the dominating share of approximately 34% in the market in 2024, driven by the growing surgeries. The minimally invasive devices were used mostly for different GI disorders. Additionally, their affordability and accessibility enhanced their adoption rates. Thus, this enhanced the market growth.
By application type, the urological surgery segment is expected to show the fastest growth rate during the upcoming years. Due to growing urological diseases, the use of minimally invasive surgeries is increasing. They are being used due to growing advancements and patient demand. Moreover, the use of robotic surgeries is also increasing.
By end user, the hospitals segment dominated the global market with approximately 58% share in 2024, because of advanced surgical infrastructure. The large patient volumes also increased the demand for minimally invasive surgeries. Moreover, the presence of various departments also increased their use. Additionally, the presence of policies also contributed to the same.
By end user, the ambulatory surgery centers (ASCs) segment is expected to show the highest growth during the upcoming years. The cost-efficient minimally invasive surgeries are offered by these centres. The growing outpatient trends are also increasing their demand. Furthermore, advanced technologies, along with skilled personnel, are enhancing the surgical procedures. Thus, this is increasing their use to enhance the patient outcomes.
North America dominated the minimally invasive surgery market share 42% in 2024. North America consisted of a well-developed healthcare infrastructure, which increased the utilization of the minimally invasive surgical devices, enhancing the surgeries. The presence of strong reimbursement polices increased their use. Moreover, there was a growth in the adoption of the robotic-assisted systems. Thus, this enhanced the market growth.
Due to growing chronic diseases in the U.S., the use of minimally invasive surgeries is increasing. At the same time, the presence of advanced healthcare systems is increasing the adoption of advanced minimally invasive technologies. Additionally, the presence of reimbursement polices is increasing their use. Moreover, various innovations are also contributing to the same.
The use of minimally invasive surgeries in Canada is increasing due to a growing aging population and disease burden. The growing patient awareness is also increasing their demand. At the same time, advancements such as the development of handheld instruments or robotic systems are also growing. These developments are also being supported by government funding.
Asia Pacific is expected to host the fastest-growing minimally invasive surgery market during the forecast period. The medical tourism in the Asia Pacific is increasing due to growing adoption of minimally invasive surgical tools and systems, and their affordability. The hospital's capacity is also expanding, which is increasing its adoption rates. Similarly, the utilization of robotic surgeries is also increasing. Moreover, growing diseases, burden, and patient demand are driving their use and adoption. At the same time, the growing technological advancements and growing support are enhancing their use. Thus, this is promoting the market growth.
The development of advanced technologies and techniques, such as improved imaging, AI, and robotics, to enhance the surgical precision and minimize the recovery time, is the main focus in the R&D of minimally invasive surgery.
Key Players: Medtronic plc, Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson, Boston Scientific Corporation, Zimmer Biomet Holdings, Inc., Olympus Corporation.
The clinical trials and regulatory approval of the minimally invasive surgery involve the evaluation of their effectiveness and safety for their intended use.
Key Players: Medtronic plc, Intuitive Surgical Inc., Johnson & Johnson, Boston Scientific Corporation.
The distribution to the hospitals and pharmacies of minimally invasive surgery includes the supply of specialized surgical devices, equipment, and associated medications by a multi-tiered supply chain.
Key Players: Medtronic plc, Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson.
To enhance the recovery and patient satisfaction, the patient support and services focus on providing patient-centred counselling, pre-operative education, and post-operative care.
Key Players: Medtronic plc, Intuitive Surgical Inc., Practo, Doctors App, HealthPlix, CipherHealth.
In September 2025, the Consultant Cardiothoracic Surgeon, Dr. Mallampati Sameer, at Renova Century Hospitals, stated that, as there is a growth in the Transcatheter Aortic Valve Replacement (TAVR) and other catheter-based interventions, and with the growing patients' demand for minimally invasive options with quicker recovery, there is a need to evolve the surgeries. Thus, they are moving forward with these innovations with the launch of Minimally Invasive Cardiac Surgery (MICS).
By Procedure Type
By Device Type
By Application
By End User
By Region
August 2025
July 2025
July 2025
July 2025